1. Beware of patient variations with different methadone formulations

   News item 25 April 2020 Pages: 1 - 1

2. Malaysia's NPRA advises of anaphylaxis risk with guselkumab

   News item 25 April 2020 Pages: 2 - 2

3. Replacement gentamicin injection may cause bronchoconstriction

   News item 25 April 2020 Pages: 3 - 3

4. Erice Call for Change: enhancing quality and safety of care

   News item 25 April 2020 Pages: 4 - 4

5. Adverse drug reactions under-reported in South Africa

   Clinical study 25 April 2020 Pages: 5 - 5

6. Adverse events of influenza virus vaccines vary

   Clinical study 25 April 2020 Pages: 6 - 6

7. DPP-4 inhibitors do not increase risk of serious muscular disorders

   Clinical study 25 April 2020 Pages: 7 - 7

8. Drug-induced liver injury and hospitalisation in Pakistan

   Clinical study 25 April 2020 Pages: 8 - 8

9. Estimation of adverse event incidence with acellular pertussis vaccine

   Clinical study 25 April 2020 Pages: 9 - 9

10. Live herpes zoster vaccine not associated with MI, stroke or rash

    Clinical study 25 April 2020 Pages: 10 - 10

11. Safety of DTwP HepB Hib vaccine plus oral polio vaccine

    Clinical study 25 April 2020 Pages: 11 - 11

12. Safety profiles of intradermal and percutaneous BCG vaccines differ

    Clinical study 25 April 2020 Pages: 12 - 12

13. Other adverse reaction research

    News item 25 April 2020 Pages: 13 - 13

14. Aciclovir

    Case report 25 April 2020 Pages: 14 - 14

15. Aciclovir

    Case report 25 April 2020 Pages: 15 - 15

16. Adalimumab

    Case report 25 April 2020 Pages: 16 - 16

17. Albendazole/ivermectin/prednisolone

    Case report 25 April 2020 Pages: 17 - 17

18. Alendronic acid/pamidronic acid

    Case report 25 April 2020 Pages: 18 - 18

19. Alfuzosin/terazosin

    Case report 25 April 2020 Pages: 19 - 19

20. Alteplase

    Case report 25 April 2020 Pages: 20 - 20

21. Alteplase/aspirin/clopidogrel

    Case report 25 April 2020 Pages: 21 - 21

22. Amantadine

    Case report 25 April 2020 Pages: 22 - 22

23. Amoxicillin

    Case report 25 April 2020 Pages: 23 - 23

24. Amoxicillin/clavulanic-acid/dexamethasone/prednisone

    Case report 25 April 2020 Pages: 24 - 24

25. Amphotericin-B-liposomal

    Case report 25 April 2020 Pages: 25 - 25

26. Antibacterials

    Case report 25 April 2020 Pages: 26 - 26

27. Antibacterials/antifungals

    Case report 25 April 2020 Pages: 27 - 27

28. Antiepileptic drugs

    Case report 25 April 2020 Pages: 28 - 28

29. Antiepileptic drugs

    Case report 25 April 2020 Pages: 29 - 29

30. Antihypertensives/atropine

    Case report 25 April 2020 Pages: 30 - 30

31. Antineolastics/docetaxel

    Case report 25 April 2020 Pages: 31 - 31

32. Antineoplastics

    Case report 25 April 2020 Pages: 32 - 32

33. Antineoplastics

    Case report 25 April 2020 Pages: 33 - 33

34. Antineoplastics

    Case report 25 April 2020 Pages: 34 - 34

35. Antineoplastics

    Case report 25 April 2020 Pages: 35 - 35

36. Antineoplastics

    Case report 25 April 2020 Pages: 36 - 36

37. Antineoplastics

    Case report 25 April 2020 Pages: 37 - 37

38. Antineoplastics

    Case report 25 April 2020 Pages: 38 - 38

39. Antineoplastics

    Case report 25 April 2020 Pages: 39 - 39

40. Antineoplastics/Antithymocte-globulin

    Case report 25 April 2020 Pages: 40 - 40

41. Antineoplastics/CAR-T-cell-therapies

    Case report 25 April 2020 Pages: 41 - 41

42. Antiparkinsonians

    Case report 25 April 2020 Pages: 42 - 42

43. Antipsychotics

    Case report 25 April 2020 Pages: 43 - 43

44. Antipsychotics

    Case report 25 April 2020 Pages: 44 - 44

45. Antipsychotics/anxiolytics/morphine

    Case report 25 April 2020 Pages: 45 - 45

46. Antiretrovirals

    Case report 25 April 2020 Pages: 46 - 46

47. Antivirals/immunosuppressants interaction

    Case report 25 April 2020 Pages: 47 - 47

48. Apomorphine/levodopa

    Case report 25 April 2020 Pages: 48 - 48

49. Apomorphine/sodium-chloride

    Case report 25 April 2020 Pages: 49 - 49

50. Apremilast/prednisone

    Case report 25 April 2020 Pages: 50 - 50